Global equine healthcare market was valued at $ 2.1 billion in 2022 and is likely to reach $ 3.8 billion by 2032, registering a CAGR of 5.6% over the forecast period of 2023-2032. The equine healthcare market is a vital segment of the veterinary industry, focusing on the well-being, disease prevention, and treatment of horses. This market includes pharmaceuticals, vaccines, medical devices, and nutritional supplements designed to enhance equine health. As equestrian sports, horse racing, and recreational horseback riding continue to grow, so does the demand for quality healthcare solutions for horses.